USFDA gives nod to Aleor for Nystatin and Triamcinolone Acetonide Ointment

Nystatin and Triamcinolone Acetonide Ointment has an estimated market size of $4 million for twelve months ending Dec 2021 according to IQVIA, added the statement.

75
USFDA
Picture: Pixabay

Last Updated on March 10, 2022 by The Health Master

Alembic Pharmaceuticals today announced that its joint venture Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram.

The approved ANDA is therapeutically equivalent to the Reference Listed Drug product (RLD) Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 U/g/0.1 per cent, of Taro Pharmaceuticals, Alembic Pharma notified in a statement.

The statement further said that Nystatin and Triamcinolone Acetonide Ointment is indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment.

Nystatin and Triamcinolone Acetonide Ointment has an estimated market size of $4 million for twelve months ending Dec 2021 according to IQVIA, added the statement.

USFDA approves expanded use of cancer drug Opdivo

USFDA gives nod to Lupin for generic Jublia topical solution

USFDA gives nod to Lupin for Sevelamer Hydrochloride Tablets, 800 mg

USFDA approves this drug for bone marrow cancer treatment

USFDA gives nod to Unichem Laboratories for Divalproex Sodium

USFDA approves this drug for all heart patients to cut death, hospitalization risk

ICMR in collaboration with pharma companies to develop Dengue vaccine

DCGI gives nod to Zydus Oxemia to treat anaemia

Pfizer recalls this BP drug on potential cancer-causing impurity

Phase-3 Clinical Trial permission of Covovax as booster dose recommended

NPPA fixes retail price of Normal Human Immunoglobulin 5% Solution

Clarification sought from CDSCO on approval status of Clotrimazole 1% mouth paint

Govt recommends imposition of anti-dumping duty on import of Dicyclohexylcarbodiimide from China

USFDA approves expanded use of cancer drug Opdivo

Govt releases draft Unani Pharmacopoeia of India

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner